Published in Nat Rev Cancer on March 10, 2011
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med (2013) 2.10
Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell (2013) 1.63
Lineage conversion methodologies meet the reprogramming toolbox. Nat Cell Biol (2012) 1.56
Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell (2013) 1.47
Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells. Proc Natl Acad Sci U S A (2012) 1.46
Reprogrammed cells for disease modeling and regenerative medicine. Annu Rev Med (2013) 1.45
Pericytes of Multiple Organs Do Not Behave as Mesenchymal Stem Cells In Vivo. Cell Stem Cell (2017) 1.45
A simple tool to improve pluripotent stem cell differentiation. Nat Methods (2013) 1.42
Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet (2012) 1.38
Report: Stem cell applications in neurological practice, an expert group consensus appraisal. Ann Indian Acad Neurol (2016) 1.37
Neural stem cells: historical perspective and future prospects. Neuron (2011) 1.31
Adipose-Derived Stem Cells (ADSC) and Aesthetic Surgery: A Mini Review. World J Plast Surg (2013) 1.28
Quality control: Genome maintenance in pluripotent stem cells. J Cell Biol (2014) 1.27
Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent. Stem Cells Transl Med (2012) 1.24
Advances in stem cell therapy for spinal cord injury. J Clin Invest (2012) 1.24
Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. PLoS One (2012) 1.24
Remote control of induced dopaminergic neurons in parkinsonian rats. J Clin Invest (2014) 1.23
Perspectives on whole-organ assembly: moving toward transplantation on demand. J Clin Invest (2012) 1.22
The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells. Cell Cycle (2013) 1.20
Immunogenicity of pluripotent stem cells and their derivatives. Circ Res (2013) 1.19
Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors. Sci Rep (2013) 1.12
Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency. Sci Rep (2012) 1.11
Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. Circ Res (2014) 1.09
Stem cells in plastic surgery: a review of current clinical and translational applications. Arch Plast Surg (2013) 1.09
Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein. Stem Cell Reports (2015) 1.08
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway. Cell Cycle (2013) 1.08
Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity. Theranostics (2012) 1.08
The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells. Cell Cycle (2012) 1.04
An automated system for high-throughput single cell-based breeding. Sci Rep (2013) 1.02
Pivots of pluripotency: the roles of non-coding RNA in regulating embryonic and induced pluripotent stem cells. Biochim Biophys Acta (2012) 1.00
The RB family is required for the self-renewal and survival of human embryonic stem cells. Nat Commun (2012) 0.99
Stem cell transplantation in neurodegenerative disorders of the gastrointestinal tract: future or fiction? Gut (2011) 0.98
A scalable approach to prevent teratoma formation of human embryonic stem cells. J Biol Chem (2012) 0.97
Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors. Protein Cell (2014) 0.96
Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin). Cell Cycle (2012) 0.95
Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease. Clin Sci (Lond) (2013) 0.95
Development of an inducible caspase-9 safety switch for pluripotent stem cell-based therapies. Mol Ther Methods Clin Dev (2014) 0.94
High glutathione and glutathione peroxidase-2 levels mediate cell-type-specific DNA damage protection in human induced pluripotent stem cells. Stem Cell Reports (2015) 0.94
Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration. Tissue Eng Part A (2014) 0.94
MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation. Cancer Res (2012) 0.93
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies. Stem Cells Transl Med (2015) 0.92
Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk. Stem Cells Transl Med (2012) 0.90
Genomic analysis of hESC pedigrees identifies de novo mutations and enables determination of the timing and origin of mutational events. Cell Rep (2013) 0.90
Current concepts: the role of mesenchymal stem cells in the management of knee osteoarthritis. Sports Health (2015) 0.90
Discovery of molecular associations among aging, stem cells, and cancer based on gene expression profiling. Chin J Cancer (2013) 0.89
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer. Oncotarget (2015) 0.89
Functional consequences of 17q21.31/WNT3-WNT9B amplification in hPSCs with respect to neural differentiation. Cell Rep (2015) 0.89
To clone or not to clone? Induced pluripotent stem cells can be generated in bulk culture. PLoS One (2013) 0.88
Direct reprogramming of human fibroblasts to hepatocyte-like cells by synthetic modified mRNAs. PLoS One (2014) 0.88
Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells. Nat Commun (2016) 0.88
Stepwise differentiation of pluripotent stem cells into osteoblasts using four small molecules under serum-free and feeder-free conditions. Stem Cell Reports (2014) 0.88
Suicide Gene Therapy for Cancer - Current Strategies. J Genet Syndr Gene Ther (2013) 0.87
Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective. Curr Gene Ther (2013) 0.87
DNp73 improves generation efficiency of human induced pluripotent stem cells. BMC Cell Biol (2012) 0.87
Stem cell therapy: an exercise in patience and prudence. Philos Trans R Soc Lond B Biol Sci (2013) 0.86
Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability. Genome Med (2012) 0.86
In vivo cell reprogramming towards pluripotency by virus-free overexpression of defined factors. PLoS One (2013) 0.86
Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells. Cell Death Differ (2017) 0.85
Neural stem cells: brain building blocks and beyond. Ups J Med Sci (2012) 0.85
Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy. J Cancer Res Ther (Manch) (2014) 0.85
Transgene excision has no impact on in vivo integration of human iPS derived neural precursors. PLoS One (2011) 0.83
Identification of cisplatin-regulated metabolic pathways in pluripotent stem cells. PLoS One (2013) 0.83
Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration. Mol Cell Ther (2013) 0.83
The decision on the "optimal" human pluripotent stem cell. Stem Cells Transl Med (2014) 0.83
Oncometabolic Nuclear Reprogramming of Cancer Stemness. Stem Cell Reports (2016) 0.83
Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. Biomed Res Int (2014) 0.83
Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival. PLoS One (2015) 0.83
Cellular phenotype-dependent and -independent effects of vitamin C on the renewal and gene expression of mouse embryonic fibroblasts. PLoS One (2012) 0.82
Genome-wide CNV analysis in mouse induced pluripotent stem cells reveals dosage effect of pluripotent factors on genome integrity. BMC Genomics (2014) 0.82
Augmenting peripheral nerve regeneration using stem cells: A review of current opinion. World J Stem Cells (2015) 0.82
Safeguarding clinical translation of pluripotent stem cells with suicide genes. Organogenesis (2013) 0.82
Aneuploid embryonic stem cells exhibit impaired differentiation and increased neoplastic potential. EMBO J (2016) 0.82
Selective cell elimination in vitro and in vivo from tissues and tumors using antibodies conjugated with a near infrared phthalocyanine. RSC Adv (2015) 0.82
Metabolic control of cancer cell stemness: Lessons from iPS cells. Cell Cycle (2015) 0.81
Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas. Stem Cell Reports (2016) 0.81
Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy. Stem Cells Dev (2014) 0.81
What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury? BMC Neurol (2011) 0.81
Establishment of transgene-free induced pluripotent stem cells reprogrammed from human stem cells of apical papilla for neural differentiation. Stem Cell Res Ther (2012) 0.81
Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies. Mol Cell Ther (2014) 0.81
Computational analysis of expression of human embryonic stem cell-associated signatures in tumors. BMC Res Notes (2011) 0.81
Mechanisms and Functional Significance of Stroke-Induced Neurogenesis. Front Neurosci (2015) 0.81
Artificial gametes from stem cells. Clin Exp Reprod Med (2015) 0.81
The propensity for tumorigenesis in human induced pluripotent stem cells is related with genomic instability. Chin J Cancer (2012) 0.81
Epigenetic mechanisms of tumorigenicity manifesting in stem cells. Oncogene (2014) 0.81
Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers. BMC Biol (2014) 0.80
Fetal heart extract facilitates the differentiation of human umbilical cord blood-derived mesenchymal stem cells into heart muscle precursor cells. Cytotechnology (2014) 0.80
Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine. Stem Cells Int (2012) 0.80
Whole-organ re-engineering: a regenerative medicine approach to digestive organ replacement. Surg Today (2012) 0.79
Stem cell-based approach for the treatment of Parkinson's disease. Med J Islam Repub Iran (2015) 0.79
Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice. Sci Rep (2016) 0.79
A new class of pluripotent stem cell cytotoxic small molecules. PLoS One (2014) 0.79
NeuroD1 mediates nicotine-induced migration and invasion via regulation of the nicotinic acetylcholine receptor subunits in a subset of neural and neuroendocrine carcinomas. Mol Biol Cell (2014) 0.78
Escape Mutations, Ganciclovir Resistance, and Teratoma Formation in Human iPSCs Expressing an HSVtk Suicide Gene. Mol Ther Nucleic Acids (2016) 0.78
Targeting of herpes simplex virus 1 thymidine kinase gene sequences into the OCT4 locus of human induced pluripotent stem cells. PLoS One (2013) 0.78
Intrastriatal transplantation of adult human neural crest-derived stem cells improves functional outcome in parkinsonian rats. Stem Cells Transl Med (2014) 0.78
Pluripotent muse cells derived from human adipose tissue: a new perspective on regenerative medicine and cell therapy. Clin Transl Med (2014) 0.78
Werner Syndrome-specific induced pluripotent stem cells: recovery of telomere function by reprogramming. Front Genet (2015) 0.78
'Above all, do no harm': safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis. Stem Cell Res Ther (2014) 0.78
Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of DNASE1, DNASE1L3, DNASE2, DFFB Controlled By POLA1 Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Pluripotent Induced Stem Cells Leads to their Death. J Stem Cell Res Ther (2013) 0.78
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol (2007) 9.36
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell (2010) 7.16
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
Developmental programming of CpG island methylation profiles in the human genome. Nat Struct Mol Biol (2009) 3.96
Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell (2011) 3.73
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol (2010) 3.21
Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell (2007) 2.87
Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell (2011) 2.71
Ethics. The ISSCR guidelines for human embryonic stem cell research. Science (2007) 2.62
Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 2.53
The tumorigenicity of human embryonic stem cells. Adv Cancer Res (2008) 2.32
Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development (2006) 2.27
Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells (2005) 2.24
Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells (2004) 2.07
Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell (2013) 2.02
Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells (2009) 1.98
Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells (2003) 1.75
Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell Dev Biol Anim (2010) 1.70
Assessing the safety of stem cell therapeutics. Cell Stem Cell (2011) 1.60
Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation (2004) 1.53
Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Hum Reprod (2004) 1.49
Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells. Nucleic Acids Res (2004) 1.39
The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol (2009) 1.39
Derivation of euploid human embryonic stem cells from aneuploid embryos. Stem Cells (2008) 1.38
Genetic analysis of the role of the reprogramming gene LIN-28 in human embryonic stem cells. Stem Cells (2009) 1.30
Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Res (2010) 1.27
Quality control: Genome maintenance in pluripotent stem cells. J Cell Biol (2014) 1.27
The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol (2004) 1.25
The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle (2009) 1.17
Human embryonic stem cells as models for aneuploid chromosomal syndromes. Stem Cells (2010) 1.15
Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. Nat Commun (2013) 1.12
Fibroblast growth factor 4 and its novel splice isoform have opposing effects on the maintenance of human embryonic stem cell self-renewal. Stem Cells (2008) 1.11
Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profiles. Nat Protoc (2013) 1.11
Expanding the boundaries of embryonic stem cells. Cell Stem Cell (2012) 1.06
The International Stem Cell Initiative: toward benchmarks for human embryonic stem cell research. Nat Biotechnol (2005) 1.06
Human embryonic stem cells as a cellular model for human disorders. Mol Cell Endocrinol (2006) 1.05
Publishing SNP genotypes of human embryonic stem cell lines: policy statement of the International Stem Cell Forum Ethics Working Party. Stem Cell Rev (2011) 1.02
Genomic stability in reprogramming. Curr Opin Genet Dev (2012) 1.02
Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells. PLoS One (2009) 1.02
A molecular view on pluripotent stem cells. FEBS Lett (2002) 1.02
High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells (2012) 1.01
Study of hepatocyte differentiation using embryonic stem cells. J Cell Biochem (2005) 1.01
Clonal analysis of human embryonic stem cell differentiation into teratomas. Stem Cells (2007) 1.00
Integration and differentiation of human embryonic stem cells transplanted to the chick embryo. Dev Dyn (2002) 0.99
Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. Stem Cells (2006) 0.98
Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. J Mol Cell Biol (2012) 0.96
Human embryonic stem cells as a model for early human development. Best Pract Res Clin Obstet Gynaecol (2004) 0.95
Genetic instability in human induced pluripotent stem cells: classification of causes and possible safeguards. Cell Cycle (2010) 0.95
Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells. Nat Struct Mol Biol (2011) 0.95
The effect of overexpression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells. Stem Cells (2006) 0.94
Identification of novel imprinted differentially methylated regions by global analysis of human-parthenogenetic-induced pluripotent stem cells. Stem Cell Reports (2013) 0.94
Benefits of utilizing gene-modified iPSCs for clinical applications. Cell Stem Cell (2010) 0.92
Human embryonic stem cells: the battle between self-renewal and differentiation. Regen Med (2006) 0.88
Molecular and functional characterizations of gastrula organizer cells derived from human embryonic stem cells. Stem Cells (2011) 0.87
Characterization of gastrulation-stage progenitor cells and their inhibitory crosstalk in human embryoid bodies. Stem Cells (2010) 0.86
Human embryonic stem cells from aneuploid blastocysts identified by pre-implantation genetic screening. In Vitro Cell Dev Biol Anim (2010) 0.86
Factors controlling human embryonic stem cell differentiation. Methods Enzymol (2003) 0.85
Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells. J Cell Mol Med (2010) 0.83
Cell lines derived from human parthenogenetic embryos can display aberrant centriole distribution and altered expression levels of mitotic spindle check-point transcripts. Stem Cell Rev (2009) 0.83
A computerized database-scan to identify c-MYC targets. Gene (2002) 0.82
Reprogramming of the MHC-I and its regulation by NFκB in human-induced pluripotent stem cells. Stem Cells (2012) 0.81
Involvement of parental imprinting in the antisense regulation of onco-miR-372-373. Nat Commun (2013) 0.81
Targeting pancreatic progenitor cells in human embryonic stem cell differentiation for the identification of novel cell surface markers. Stem Cell Rev (2012) 0.80
The "brainy side" of human embryonic stem cells. J Neurosci Res (2004) 0.80
New balance in pluripotency: reprogramming with lineage specifiers. Cell (2013) 0.80
The in vitro survival of human monosomies and trisomies as embryonic stem cells. Stem Cell Res (2012) 0.79
Human pluripotent stem cells with distinct X inactivation status show molecular and cellular differences controlled by the X-Linked ELK-1 gene. Cell Rep (2013) 0.79
Aneuploid human embryonic stem cells: origins and potential for modeling chromosomal disorders. Regen Med (2011) 0.78
Manipulation of the human genome in human embryonic stem cells. Stem Cell Rev (2005) 0.77
New ISSCR guidelines: clinical translation of stem cell research. Lancet (2016) 0.77
Differentiation and genetic manipulation of human embryonic stem cells and the analysis of the cardiovascular system. Trends Cardiovasc Med (2003) 0.76
Stepwise differentiation of human embryonic stem cells into early endoderm derivatives and their molecular characterization. Stem Cell Res (2011) 0.76
Brief reports: Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha. Stem Cells (2015) 0.76
DUXO, a novel double homeobox transcription factor, is a regulator of the gastrula organizer in human embryonic stem cells. Stem Cell Res (2012) 0.76
Corrigendum: Hallmarks of pluripotency. Nature (2015) 0.75
Epigenetic mechanism of FMR1 inactivation in Fragile X syndrome. Int J Dev Biol (2017) 0.75
Human ES cell lines--introduction. In Vitro Cell Dev Biol Anim (2010) 0.75